机译:Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent Inhibitors
Department of Cancer Biology, Dana-Farber Cancer Institute;
Department of Medicine, Division of Hematology, Brigham and Women's Hospital, Harvard Medical School;
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital;
PI5P4K; phosphoinositide; autophagy; covalent inhibitor; kinase; cancer; drug discovery;